Richardson P - Search Results

1

Use of defibrotide in the treatment and prevention of veno-occlusive disease.

Richardson P, Linden E, Revta C, Ho V. Richardson P, et al. Expert Rev Hematol. 2009 Aug;2(4):365-76. doi: 10.1586/ehm.09.30. Expert Rev Hematol. 2009. PMID: 21082942 Review.

2

Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population.

Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D, Kinchla NM, Neuberg D, Waller EK, Antin JH, Soiffer R, Vredenburgh J, Lill M, Woolfrey AE, Bearman SI, Iacobelli M, Fareed J, Guinan EC. Richardson PG, et al. Blood. 1998 Aug 1;92(3):737-44. Blood. 1998. PMID: 9680339 Free article. Review.

3

Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.

Wadleigh M, Ho V, Momtaz P, Richardson P. Wadleigh M, et al. Among authors: richardson p. Curr Opin Hematol. 2003 Nov;10(6):451-62. doi: 10.1097/00062752-200311000-00010. Curr Opin Hematol. 2003. PMID: 14564177 Review.

4

Routine screening for psychosocial distress following hematopoietic stem cell transplantation.

Lee SJ, Loberiza FR, Antin JH, Kirkpatrick T, Prokop L, Alyea EP, Cutler C, Ho VT, Richardson PG, Schlossman RL, Fisher DC, Logan B, Soiffer RJ. Lee SJ, et al. Among authors: richardson pg. Bone Marrow Transplant. 2005 Jan;35(1):77-83. doi: 10.1038/sj.bmt.1704709. Bone Marrow Transplant. 2005. PMID: 15502851

5

Post-transplant hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.

Ho V, Momtaz P, Didas C, Wadleigh M, Richardson P. Ho V, et al. Among authors: richardson p. Rev Clin Exp Hematol. 2004 Jun 1;8(1):E3. Rev Clin Exp Hematol. 2004. PMID: 16029969 Review.

6

New therapies for the treatment of multiple myeloma.

Richardson P. Richardson P. Clin Adv Hematol Oncol. 2005 May;3(5):345-6. Clin Adv Hematol Oncol. 2005. PMID: 16167007 No abstract available.

7

Defibrotide, a polydisperse mixture of single-stranded phosphodiester oligonucleotides with lifesaving activity in severe hepatic veno-occlusive disease: clinical outcomes and potential mechanisms of action.

Kornblum N, Ayyanar K, Benimetskaya L, Richardson P, Iacobelli M, Stein CA. Kornblum N, et al. Among authors: richardson p. Oligonucleotides. 2006 Spring;16(1):105-14. doi: 10.1089/oli.2006.16.105. Oligonucleotides. 2006. PMID: 16584299 Review.

8

Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.

Ho VT, Revta C, Richardson PG. Ho VT, et al. Among authors: richardson pg. Bone Marrow Transplant. 2008 Feb;41(3):229-37. doi: 10.1038/sj.bmt.1705899. Epub 2007 Nov 12. Bone Marrow Transplant. 2008. PMID: 17994121 Review.

9

Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease.

Benimetskaya L, Wu S, Voskresenskiy AM, Echart C, Zhou JF, Shin J, Iacobelli M, Richardson P, Ayyanar K, Stein CA. Benimetskaya L, et al. Among authors: richardson p. Blood. 2008 Nov 15;112(10):4343-52. doi: 10.1182/blood-2008-04-149682. Epub 2008 Aug 18. Blood. 2008. PMID: 18711003 Free article.

10

Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.

Cutler C, Stevenson K, Kim HT, Richardson P, Ho VT, Linden E, Revta C, Ebert R, Warren D, Choi S, Koreth J, Armand P, Alyea E, Carter S, Horowitz M, Antin JH, Soiffer R. Cutler C, et al. Among authors: richardson p. Blood. 2008 Dec 1;112(12):4425-31. doi: 10.1182/blood-2008-07-169342. Epub 2008 Sep 5. Blood. 2008. PMID: 18776081 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,362 results

Search Page